Immunomodulatory effects of non-psychoactive cannabinoids in a model of metabolic dysfunction-associated steatotic liver disease (MASLD) 2232983
Emerging evidence suggests that activation of different immune cell populations contributes to the progression of MASLD to advanced MASH. Thus, with lipogenic and fibrotic markers, exploring liver innate and adaptive immune cell activation and recruitment can enhance understanding of MASLD progression and therape...